Monday, July 18, 2011

Seaside Therapeutics Presents Data On Potential Pharmaceutical Treatment For Improving Social Impairment In Autism Spectrum Disorders

Autism News From Medical News Today
Seaside Therapeutics announced that data on its clinical candidate, STX209, was presented today in an oral presentation at the 42nd Autism Society National Conference in Orlando, FL, by Barbara Rathmell, M.D., Senior Medical Director at Seaside Therapeutics...
Sent with Reeder
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)